UNLABELLED: The utility of N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) and Brain Natriuretic Peptide (BNP) for detecting left ventricular (LV) diastolic dysfunction in hypertensive patients without heart failure symptoms is unclear. In this study, we investigated the relation between NT-proBNP plasma levels and LV diastolic dysfunction in hypertensive patients without systolic dysfunction. METHOD: We studied 40 ambulatory patients (26 women, mean age 52 +/- 5) with controlled hypertension. LV diastolic function was assessed with conventional Doppler, by means of mitral inflow and with tissue Doppler echocardiography by means of mitral annulus. The ratio of early diastolic transmitral E wave velocities to tissue Doppler mitral annulus early diastolic E' wave velocities (E/E'), was used to detect LV filling pressures. Patients were divided in three groups according to E/E' ratios < 10 (group I), E/E' ratios ''between'' 10 and 15 (group II) and E/E' ratios > 15 (group III). Plasma concentrations of NT-proBNP were measured by electro chemiluminescence's immunoassay. RESULTS: The NT-proBNP blood levels were positively correlated significantly with E/E' ratio (r = 0.80, P < 0.0001). Patients with elevated LV end diastolic pressure (LVEDP), defined as E/E' > 15 (n = 8) had highest NT-proBNP (203 +/- 75 pg/ml) levels. E/E' 10 to 15 group (n = 16) had a mean NT-proBNP level of 71 +/- 26 pg/ml, and those with E/E' < 10 (n = 16) had 39 +/- 20 pg/ml. A NT-proBNP value of 119 pg/ml had a sensitivity of 87%, a specificity of 100% for predicting E/E' > 15. CONCLUSION: The assessment of the blood concentration of NT-proBNP is of potential value for identification of those patients with hypertension to detect early cardiovascular changes, especially LV diastolic dysfunction.
UNLABELLED: The utility of N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) and Brain Natriuretic Peptide (BNP) for detecting left ventricular (LV) diastolic dysfunction in hypertensivepatients without heart failure symptoms is unclear. In this study, we investigated the relation between NT-proBNP plasma levels and LV diastolic dysfunction in hypertensivepatients without systolic dysfunction. METHOD: We studied 40 ambulatory patients (26 women, mean age 52 +/- 5) with controlled hypertension. LV diastolic function was assessed with conventional Doppler, by means of mitral inflow and with tissue Doppler echocardiography by means of mitral annulus. The ratio of early diastolic transmitral E wave velocities to tissue Doppler mitral annulus early diastolic E' wave velocities (E/E'), was used to detect LV filling pressures. Patients were divided in three groups according to E/E' ratios < 10 (group I), E/E' ratios ''between'' 10 and 15 (group II) and E/E' ratios > 15 (group III). Plasma concentrations of NT-proBNP were measured by electro chemiluminescence's immunoassay. RESULTS: The NT-proBNP blood levels were positively correlated significantly with E/E' ratio (r = 0.80, P < 0.0001). Patients with elevated LV end diastolic pressure (LVEDP), defined as E/E' > 15 (n = 8) had highest NT-proBNP (203 +/- 75 pg/ml) levels. E/E' 10 to 15 group (n = 16) had a mean NT-proBNP level of 71 +/- 26 pg/ml, and those with E/E' < 10 (n = 16) had 39 +/- 20 pg/ml. A NT-proBNP value of 119 pg/ml had a sensitivity of 87%, a specificity of 100% for predicting E/E' > 15. CONCLUSION: The assessment of the blood concentration of NT-proBNP is of potential value for identification of those patients with hypertension to detect early cardiovascular changes, especially LV diastolic dysfunction.
Authors: S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik Journal: Circulation Date: 2000-10-10 Impact factor: 29.690
Authors: Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen Journal: Eur Heart J Date: 2005-01-28 Impact factor: 29.983
Authors: N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger Journal: J Am Soc Echocardiogr Date: 1989 Sep-Oct Impact factor: 5.251
Authors: G Tissera; Daniel Piskorz; L Citta; N Citta; P Citta; L Keller; L Bongarzoni; L Mata; A Tommasi Journal: High Blood Press Cardiovasc Prev Date: 2016-09-13
Authors: Rodrigo C Santos; Ana Paula C de Faria; Natália R Barbaro; Rodrigo Modolo; Silvia E Ferreira-Melo; José R Matos-Souza; Otávio R Coelho; Juan C Yugar-Toledo; Vanessa Fontana; David Calhoun; Heitor Moreno Journal: Eur J Clin Pharmacol Date: 2013-11-24 Impact factor: 2.953